Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18055865 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria
Condition: Paroxysmal Hemoglobinuria, Nocturnal
Intervention: Drug: Eculizumab
2 Unknown  Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation
Condition: Kidney; Complications, Allograft
Intervention: Drug: eculizumab

Study has passed its completion date and status has not been verified in more than two years.